The effects of tegaserod, a 5-HT4 receptor agonist, on gastric emptying in a murine model of diabetes mellitus

Neurogastroenterology and Motility

Volumn 17, Issue 5, 2005, Pages 738-743

  Crowell, Michael D ^a,b   Mathis, C ^a   Schettler, V A ^a,b   Yunus, T ^a   Lacy, B E ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

Diabetes mellitus; Gastroparesis; Serotonin type 4 receptor agonist; Tegaserod

Indexed keywords

1 METHYL 3 INDOLECARBOXYLIC ACID [1 [2 (METHYLSULFONYLAMINO)ETHYL] 4 PIPERIDINYLMETHYL] ESTER; SEROTONIN 4 AGONIST; TEGASEROD;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; FEMALE; GLUCOSE TOLERANCE TEST; INTESTINE TRANSIT TIME; NONHUMAN; PRIORITY JOURNAL; STOMACH EMPTYING; STOMACH PARESIS;

ANIMALS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; FEMALE; GASTRIC EMPTYING; GLUCOSE; INDOLES; MICE; MICE, INBRED C57BL; RECEPTORS, SEROTONIN, 5-HT4; SEROTONIN AGONISTS;

EID: 25844450030     PISSN: 13501925     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2982.2005.00681.x     Document Type: Article

References (27)

1. Horowitz M, Maddox A, Maddern GJ, Chatterton BE, Wishart J, Shearman DJ. Effect of cisapride on gastric and esophageal emptying in insulin-dependent diabetes mellitus. Gastroenterology 1987; 92: 1899-907.
2. Carson KA, Bossen EH, Hanker JS. Peripheral neuropathy in mouse hereditary diabetes mellitus. II. Ultrastructural correlates of degenerative and regenerative changes. Neuropathol Appl Neurobiol 1980; 6(5): 361-74.
3. Giachetti A. The functional state of sympathetic nerves in spontaneously diabetic mice. Diabetes 1978; 27(10): 969-74.
4. Hanker JS, Ambrose WW, Yates PE, Koch GG, Carson KA. Peripheral neuropathy in mouse hereditary diabetes mellitus. I. Comparison of neurologic, histologic, and morphometric parameters with dystonic mice. Acta Neuropathol (Berl) 1980; 51(2): 145-53.
5. Robertson DM, Sima AA. Diabetic neuropathy in the mutant mouse [C57BL/ks(db/db)]: a morphometric study. Diabetes 1980; 29(1): 60-67.
6. Sima AA, Robertson DM. Peripheral neuropathy in mutant diabetic mouse [C57BL/Ks (db/db)]. Acta Neuropathol 1978; 41(85): 89.
7. Norido F, Canella R, Zanoni R, Gorio A. Development of diabetic neuropathy in the C57BL/Ks (db/db) mouse and its treatment with gangliosides. Exp Neurol 1984; 83(2): 221-32.
8. Grider JR, Kuemmerle JF, Jin JG. 5-HT released by mucosal stimuli initiates peristalsis by activating 5-HT4/5-HT1p receptors on sensory CGRP neurons. Am J Physiol 1996; 270(5 Pt 1): G778-82.
9. Grider JR, Foxx-Orenstein AE, Jin JG. 5-Hydroxytryptamine4 receptor agonists initiate the peristaltic reflex in human, rat, and guinea pig intestine. Gastroenterology 1998; 115(2): 370-80.
10. Kellum JM, Albuquerque FC, Stoner MC, Harris RP. Stroking human jejunal mucosa induces 5-HT release and Cl-secretion via afferent neurons and 5-HT4 receptors. Am J Physiol 1999; 277(3 Pt 1): G515-20.
11. Borovicka J, Lehmann R, Kunz P et al. Evaluation of gastric emptying and motility in diabetic gastroparesis with magnetic resonance imaging: effects of cisapride. Am J Gastroenterol 1999; 94(10): 2866-73.
12. Chang CS, Lien HC, Yeh HZ, Poon SK, Tung CF, Chen GH. Effect of cisapride on gastric dysrhythmia and emptying of indigestible solids in type-II diabetic patients. Scand J Gastroenterol 1998; 33(6): 600-4.
13. Dutta U, Padhy AK, Ahuja V, Sharma MP. Double blind controlled trial of effect of cisapride on gastric emptying in diabetics. Trop Gastroenterol 1999; 20(3): 116-9.
14. Nguyen A, Camilleri M, Kost LJ et al. SDZ HTF 919 stimulates canine colonic motility and transit in vivo. J Pharmacol Exp Ther 1997; 280(3): 1270-6.
15. Prather CM, Camilleri M, Zinsmeister AR, McKinzie S, Thomforde G. Tegaserod accelerates orocecal transit in patients with constipation-predominant irritable bowel syndrome. Gastroenterology 2000; 118(3): 463-8.
16. Degen L, Matzinger D, Merz M et al. Tegaserod, a 5-HT4 receptor partial agonist, accelerates gastric emptying and gastrointestinal transit in healthy male subjects. Aliment Pharmacol Ther 2001; 15(11): 1745-51.
17. Tougas G, Chen Y, Luo D, Salter J, D'Elia T, Earnest D. Tegaserod improves gastric emptying in patients with gastroparesis and dyspetic symptoms. Gastroenterology 2003; 124: A54.
18. Kuo WH, Wadwa KS, Ferris CD. Cephalosporin antibiotics accelerate gastric emptying in mice. Dig Dis Sci 1998; 43(8): 1690-4.
19. Horowitz M, Fraser RJ. Gastroparesis: diagnosis and management. Scand J Gastroenterol Suppl 1995; 213: 7-16.
20. Lin HC. Abnormal intestinal feedback in disorders of gastric emptying. Dig Dis Sci 1994; 39(Suppl. 12): 54S-5S.
21. He CL, Soffer EE, Ferris CD, Walsh RM, Szurszewski JH, Farrugia G. Loss of interstitial cells of cajal and inhibitory innervation in insulin-dependent diabetes. Gastroenterology 2001; 121(2): 427-34.
22. Schvarcz E, Palmer M, Aman J, Berne C. Accelerated gastric emptying during hypoglycaemia is not associated with changes in plasma motilin levels. Acta Diabetol 1997; 34(3): 194-8.
23. Zahorska-Markiewickz B, Jonderko K, Lelek A, Skrzypek D. Gastric emptying in obesity. Hum Nutr Clin Nutr 1986; 40(4): 309-13.
24. Lacy BE, Yu S. Tegaserod: a new 5-HT4 agonist. J Clin Gastroenterol 2002; 34(1): 27-33.
25. Takada K, Sakurai-Yamashita Y, Yamashita K et al. Regional difference in correlation of 5-HT4 receptor distribution with cholinergic transmission in the guinea pig stomach. Eur J Pharmacol 1999; 374(3): 489-94.
26. Otterson MF, Sarna SK. Gastrointestinal motor effects of erythromycin. Am J Physiol 1990; 259(3 Pt 1): G355-63.
27. Prins NH, Van Haselen JF, Lefebvre RA, Briejer MR, Akkermans LM, Schuurkes JA. Pharmacological characterization of 5-HT4 receptors mediating relaxation of canine isolated rectum circular smooth muscle. Br J Pharmacol 1999; 127(6): 1431-7.